
Orceft TZ 250mg/31.25mg Injection
Marketer
Orange Biotech Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Orceft TZ 250mg/31.25mg Injection
Cefixime and Sulbactam injection (250mg/31.25mg), marketed as Orceft TZ, combats bacterial infections by inhibiting microbial growth. Administration must be overseen by a medical professional; adherence to the prescribed dosage and schedule is crucial for optimal efficacy. Premature cessation can compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent adverse reactions necessitate immediate medical attention. Allergic responses (skin rashes, itching, swelling, respiratory distress) require prompt emergency care. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally not impairing driving ability, avoid operating vehicles if experiencing somnolence or dizziness. Adequate rest, balanced nutrition, and hydration contribute to recovery. Monitoring through laboratory tests may be employed to assess treatment response.
Uses of Orceft TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Orceft TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Orceft TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Orceft TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Orceft TZ 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam 250mg/31.25mg (Orceft TZ) injection combines the antibiotic ceftriaxone with the beta-lactamase inhibitor tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Orceft TZ 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Orceft TZ 250mg/31.25mg is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Orceft TZ 250mg/31.25mg Injection necessitates careful consideration during lactation. Mothers should temporarily discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Orceft TZ 250mg/31.25mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Orceft TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Individuals with severe hepatic impairment should use Orceft TZ 250mg/31.25mg Injection cautiously, potentially requiring dosage modification. Medical advice is recommended. Dosage alteration for Orceft TZ 250mg/31.25mg Injection is unnecessary for those with mild to moderate liver dysfunction.
What if you forget to take Orceft TZ 250mg/31.25mg Injection :
Should you forget a dose of Orceft TZ 250mg/31.25mg Injection, seek your physician's advice.
Facts to Know About Orceft TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Anti-infective agents |
